HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

935.940

+6.9320.75%

Number of Gainers:12

Number of Losers:4

Number of Flat:1

PE:- -

High:945.486

Open:929.664

Low:918.773

Close:929.009

Volume:451.18M

Turnover:3.74B

Market Cap:630.31B

Float Cap:523.10B

Loading ...

Central China Facility to Upgrade with 38 Million Yuan Investment for New Pharmaceutical Intermediate Line

BAIYUNSHAN PH Gets Nod for Norepinephrine Bitartrate Injection Consistency Assessment

BYD Electronic (International) Stock Sheds 1.7% in Hong Kong

CSPC Pharmaceutical Group Stock Climbs 2.2% in Hong Kong, Outperforms Competitors

JD Health International Stock Falls 3.5% in Hong Kong

Sinopharm Group Stock Falls 1.9% in Hong Kong

Alibaba Health Information Technology Stock Slips 3.7% in Hong Kong

AH Share Premium Rankings: Market Close Update for August 24

Hengrui Pharma's Half-Year Report: Heavy Spending Fails to Drive Growth as Former Sector Leader Struggles with Revenue Without Profit Expansion

Daiwa Raises CSPC Pharma Target Price to HK$11.2 on In-Line Interim Results

Hong Kong Stock Flash | Baiyunshan (00874) Drops Nearly 6% After Results, Net Profit Falls 16.7% in H1 Due to Higher R&D Spending

Ascletis Pharma Slips on Expecting Deeper H1 Loss on R&D Expenses

Sinopharm Group's Profit Declines 2% in H1

MT Newswires Live

Guangzhou Baiyunshan Pharma's Profit Falls 17% in H1

MT Newswires Live

Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business

Sinopharm Proposes Re-Election of Lian Wanyong, Yang Binghua as Executive Directors

Sinopharm Group H1 Revenue RMB 282,799.6 Million

THOMSON REUTERS

Sinopharm H1 Net Profit Drops 2.95% to RMB 5.18 Billion; Revenue Slips 1.13% to RMB 282.8 Billion

JD Health International (SEHK:6618) Could Be 43% Undervalued As Half Year Profit Rises

Simply Wall St.

Dunhuang's Medical Heritage Blends into Tourism, Boosting Wellness Travel Along the Silk Road

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/BK1515/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":935.94037,"timestamp":1787645292709,"preClose":929.0088,"halted":0,"volume":451183198,"delay":0,"changeRate":0.007461,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":6.93158,"latestTime":"08-25 16:00:00","open":929.6642,"high":945.48645,"low":918.7732,"amount":3740717240.5,"amplitude":0.028755,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"pbRate":1.404704,"peRate":17.150171,"turnoverRate":0.004792,"increases":11,"decrements":6,"flats":0,"marketCap":630309464960,"floatMarketCap":523103766016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":945.48645,"amplitude":0.028755,"preClose":929.0088,"low":918.7732,"pbRate":"1.404704","latestPrice":935.94037,"volume":451183198,"delay":0,"open":929.6642,"prevYearClose":1190.107,"prevWeekClose":942.615,"prevMonthClose":925.972,"prevQuarterClose":802.777,"fiveDayClose":909.79,"twentyDayClose":911.722,"sixtyDayClose":940.045,"secType":"PLATE","market":"HK","turnoverRate":0.004792,"peRate":17.150171,"marketCap":630309464960,"floatMarketCap":523103766016,"timestamp":1787645292709,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":12,"down":4,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1169750351","title":"Central China Facility to Upgrade with 38 Million Yuan Investment for New Pharmaceutical Intermediate Line","url":"https://stock-news.laohu8.com/highlight/detail?id=1169750351","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169750351?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:51","pubTimestamp":1787568675,"startTime":"0","endTime":"0","summary":"A recent environmental assessment disclosure has revealed that Henan Cylaifu Chemical Co., Ltd. is proceeding with a renovation project to produce 200 tonnes of pharmaceutical intermediates annually...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1574","09939","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189898168","title":"BAIYUNSHAN PH Gets Nod for Norepinephrine Bitartrate Injection Consistency Assessment","url":"https://stock-news.laohu8.com/highlight/detail?id=1189898168","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189898168?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:36","pubTimestamp":1787560578,"startTime":"0","endTime":"0","summary":"BAIYUNSHAN PH (00874) has announced that its wholly-owned subsidiary, Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd., has received the Drug Supplement Approval Notice from the National...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","BK0097","BK0070","BK0175","BK0028","BK1521","BK1606","BK0012","BK1191","BK0239","BK0188","BK1197","600332","BK1515","BK0096","00874","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661822143","title":"BYD Electronic (International) Stock Sheds 1.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2661822143","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661822143?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:33","pubTimestamp":1787560380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. shed 1.7% to 23.18 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.9% to 25517.33.This was the stock's second consecutive day of losses.BYD Electronic  Co. Ltd. closed 50% below its 52-week high of HK$46.70, which the company achieved Sept. 2.The stock underperformed when compared to some of its competitors, as Times Universal Group Holdings Ltd. rose 5.0%.Trading volume totaled 14.9 million shares, compared to the 50-day average of 11.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1149","BK1504","BK1580","BK1515","LU0274383008.USD","BK1540","BK1167","00285","LU0348766576.USD","LU0348767384.USD","BK1589","BK1582","BK1607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661497221","title":"CSPC Pharmaceutical Group Stock Climbs 2.2% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661497221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661497221?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:32","pubTimestamp":1787560320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rose 2.2% to 9.40 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.9% to 25517.33.CSPC Pharmaceutical Group Ltd. closed 19% short of its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock outperformed some of its competitors, as Sino Biopharmaceutical Ltd. fell 0.3%, SSY Group Ltd. fell 0.4%, and United Laboratories International Holdings Ltd. fell 0.7%.Trading volume totaled 141.6 million shares, compared to the 50-day average of 98.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","IE00BZ08YR35.GBP","KURE","LU1152091754.HKD","LU1008478684.HKD","LU1226287529.USD","LU1993786604.SGD","SG9999004220.SGD","LU1226287792.SGD","LU1226288253.USD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","LU1807302812.USD","IE0008368742.USD","LU0072913022.USD","LU1226287875.USD","LU1951186391.HKD","LU2039709279.SGD","LU1813983027.USD","LU0315179316.USD","LU0140636845.USD","LU0880133367.SGD","LU1960683339.HKD","LU0314109678.HKD","LU1226288170.HKD","LU0501845795.SGD","LU1152091168.USD","IE00BZ08YT58.USD","IE00B031HY20.USD","LU0067412154.USD","LU0326950275.SGD","01093","HK0000165453.HKD","LU1328277881.USD","IE00B543WZ88.USD","IE0008369823.USD","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661256221","title":"JD Health International Stock Falls 3.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2661256221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661256221?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:32","pubTimestamp":1787560320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. slipped 3.5% to 37.32 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.9% to 25517.33.JD Health International Inc. closed 48% short of its 52-week high of HK$71.70, which the company reached Jan. 15.Trading volume totaled 11.3 million shares, compared to the 50-day average of 10.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ62798434.SGD","BK1515","86618","BK1589","BK1591","SGXZ86797644.SGD","BK1142","BK1247","LU0456827905.SGD","BK1615","LU0051755006.USD","BK1583","06618","BK1571"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221432","title":"Sinopharm Group Stock Falls 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221432","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661221432?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:32","pubTimestamp":1787560320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. shed 1.9% to 16.33 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.9% to 25517.33.Sinopharm Group Co. Ltd. closed 27% short of its 52-week high of HK$22.34, which the company achieved Feb. 25.Despite its losses, the stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 3.3%.Trading volume totaled 5.3 million shares, compared to the 50-day average of 5.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0175","BK0188","BK1197","LU1115378108.SGD","BK0028","BK4175","BK1515","600196","LU0640798160.USD","BK0012","BK1191","SHTDY","BK0060","BK0196","BK1593","01099","02196","BK0096","BK0183","BK0187","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221435","title":"Alibaba Health Information Technology Stock Slips 3.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221435","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661221435?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:31","pubTimestamp":1787560260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Alibaba Health Information Technology Ltd. shed 3.7% to 3.14 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.9% to 25517.33.Alibaba Health Information Technology Ltd. closed 60% below its 52-week high of HK$7.91, which the company achieved Jan. 14.The stock underperformed when compared to some of its competitors, as HKT Trust & HKT Ltd. fell 1.5%.Trading volume totaled 99.9 million shares, compared to the 50-day average of 108.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09115","00241","07300","07500","03419","03115","BK1584","82800","BK1502","MCHmain","BK1501","MHImain","83115","HSI","BK1617","BK1247","03037","02800","BK1610","BK1142","07200","BK1591","BK1189","BK1515","BK1615","02833","BK1589","HK0000165453.HKD","513600","BK1571","HHImain","HSTECH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163640448","title":"AH Share Premium Rankings: Market Close Update for August 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1163640448","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163640448?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:21","pubTimestamp":1787559710,"startTime":"0","endTime":"0","summary":"As of the closing bell on August 24, the latest AH share premium data has been released, highlighting notable divergences between A-share and H-share valuations across dual-listed companies.Leading...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0165289439.USD","00553","LU0359202008.SGD","LU0329678170.USD","LU0359201612.USD","LU1048596156.SGD","LU0821914370.USD","LU0823426308.USD","03130","LU2394011477.USD","LU1105468828.SGD","LU0607220059.USD","LU2399975544.HKD","LU1769817179.HKD","LU2045819591.USD","IE00B5MMRT66.SGD","BK1610","399300","LU1188198961.HKD","00956","SG9999001226.SGD","LU0359201885.HKD","BK1140","LU0266512127.USD","IE00BZ08YS42.EUR","BK1537","LU1961090484.USD","LU0214875030.USD","BK1163","BK1170","BK1607","LU0456827905.SGD","LU0307460666.USD","BK1522","LU0043850808.USD","LU0543330566.HKD","BK1237","IE00BYV24P56.USD","LU2125910500.SGD","LU0791590937.USD","01812","BK1614","HK0000352382.USD","BK1190","LU0431992006.USD","01513","LU0128522157.USD","LU1960683339.HKD","LU0039217434.USD","01108","LU0269904917.USD","LU0561508036.HKD","LU0067412154.USD","IE00BVYPNQ40.USD","02701","82846","03308","LU0345780281.USD","HK0000306701.USD","159982","00981","BK1202","LU2039709279.SGD","LU2097828631.EUR","IE00BMCWC346.EUR","03678","01989","LU1688375341.USD","BK1574","IE0008368742.USD","BK1521","03759","IE0008369823.USD","LU0634319403.HKD","SG9999001093.SGD","LU0164865239.USD","BK1116","BK1592","LU1244550494.USD","03750","BK1507","LU1813983027.USD","LU1993786604.SGD","IE0031814852.USD","00042","BK1554","LU2476274720.SGD","LU0228659784.USD","BK1166","LU0348766576.USD","LU2008162690.USD","LU1366334578.USD","LU1720050803.USD","LU0737861772.HKD","LU0348827113.USD","HK0001040143.USD","LU0149721374.USD","LU0828238088.HKD","LU0326950275.SGD","LU0163747925.USD","01057","LU0572944931.SGD","LU0348735423.USD","LU2226246903.HKD","LU0211977185.USD","HK0001040168.HKD","LU0106252389.USD","LU1244550221.USD","BK1223","LU0164939612.USD","BK1147","LU0348814723.USD","LU0417516902.SGD","LU1282649141.HKD","LU0449509016.USD","LU1675838814.USD","LU1251922891.USD","BK1551","LU1880383366.USD","LU2097828805.USD","LU0417516738.SGD","SG9999011746.SGD","LU1831875114.USD","SG9999004220.SGD","02359","LU1808992512.USD","BK1183","BK1560","LU0181495838.USD","03328","BK1105","LU1769817096.USD","03968","LU1046422090.SGD","LU0329678337.USD","LU0348825331.USD","LU0348767384.USD","IE00BF5LJ272.USD","83188","01081","BK1193","LU0348788117.USD","LU0868486357.SGD","LU0501845795.SGD","IE00B3M56506.USD","LU1794554557.SGD","LU0862451753.SGD","LU0463099449.HKD","LU1211504680.USD","LU0229945570.USD","03986","LU0797268264.HKD","BK1122","LU0082770016.USD","LU0052750758.USD","BK1576","IE00B543WZ88.USD","LU2476274308.USD","LU0327786744.USD","LU0708995583.HKD","LU0244354667.USD","02218","BK1564","IE00B031J352.USD","07233","LU0828237510.HKD","LU1115378108.SGD","LU2294711473.HKD","LU0096374516.USD","LU0117841782.USD","LU0314109678.HKD","LU1880383440.USD","02009","BK1546","LU1481107354.HKD","00317","LU0049853897.USD","02475","LU0287142896.SGD","BK1503","BK1544","BK1526","LU0918141705.HKD","LU0320764755.SGD","LU1366334651.USD","03188","IE00B031HY20.USD","00568","LU0061477393.USD","BK1205","LU1282648689.USD","BK1144","LU2097828474.EUR","IE00BZ08YR35.GBP","LU0540923850.HKD","BK1515","LU0871576103.HKD","BK1141","IE00BVYPNP33.GBP","00668","LU1244550577.SGD","LU0140636845.USD","LU0502904849.HKD","LU0543330483.HKD","LU0531971595.HKD","LU1152091168.USD","LU0345780521.USD","LU0315179316.USD","LU0640798160.USD","LU0348816934.USD","BK1552","02691","LU0320764599.SGD","LU0886674414.USD","LU2097828557.USD","HK0000306685.HKD","LU0254981946.USD","83130","LU0455707207.USD","LU0737861699.HKD","LU0672654166.SGD","LU0228367735.SGD","HK0000352291.HKD","BK1563","02846","02899","03143","LU0516422366.SGD","LU2177674079.SGD","LU0880133367.SGD","LU1807302812.USD","02827","LU0488056044.USD","LU0648948544.HKD","LU0516423174.USD","LU2097828714.EUR","LU1504937902.USD","BK1171","LU0384037296.USD","LU1282649067.USD","BK1209","LU0791591158.USD","HK0000320223.HKD","LU0469268626.HKD","LU1242518931.SGD","03296","LU1152091754.HKD","IE00BGHQDM52.EUR","LU0509642566.USD","LU0890818403.SGD","LU0456854461.SGD","LU0210526637.USD","LU1242518857.USD","LU2778985437.USD","LU0072913022.USD","LU0164880469.USD","BK1191","00300","LU0588546209.SGD","SG9999006597.SGD","LU1770034418.SGD","BK1249","BK1135","LU0051755006.USD","02338","LU0048580855.USD","BK1558","IE0032431581.USD","LU0082770016.SGD","LU3063872942.SGD","EWH","00187","LU0231483743.USD","LU1303224171.USD","BK1240","LU0348805143.USD","LU2242644610.SGD","BK1198","BK1505","LU1719994722.HKD","BK1594","BK1161","BK1231","BK1533","LU0823426480.USD","SG9999002463.SGD","LU1224709979.USD","LU1008478684.HKD","LU1023057109.AUD","LU0456846285.SGD","LU0589944569.HKD","LU0979878070.USD","LU0516422952.EUR","SG9999014674.SGD","LU0029875118.USD","LU1988902786.USD","LU0828237940.HKD","LU1328277881.USD","00895","SG9999002828.SGD","LU0918141887.USD","BK1149","03200","LU0593848301.USD","LU2264538146.SGD","LU0266512473.USD","IE0034224299.USD","02768","LU0328353924.USD","LU0516423091.SGD","IE00B0169L03.USD","LU0173614495.USD","BK1514","BK1583","BK1186","BK1110","LU0149534421.HKD","06185","HK0000320264.USD","IE00B29SXG58.USD","LU0620787316.HKD","LU0531970944.HKD","BK1214","LU0516422440.USD","IE00BZ08YT58.USD","LU1282649810.SGD","LU0106959298.USD","01349","LU1226287529.USD","LU1064131342.USD","LU0370786039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125046383","title":"Hengrui Pharma's Half-Year Report: Heavy Spending Fails to Drive Growth as Former Sector Leader Struggles with Revenue Without Profit Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1125046383","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125046383?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:46","pubTimestamp":1787557589,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SH: 600276) unveiled its half-year financial report in August 2026, and the mid-year scorecard, which had generated considerable market anticipation, fell...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1580142542.USD","LU2097828474.EUR","LU0405327494.USD","LU1997245177.USD","LU2097828631.EUR","BK0188","LU1781817850.SGD","BK1574","LU1820825898.SGD","LU1969619763.USD","LU1064131003.USD","LU2543165471.USD","BK1161","LU0405327148.USD","600276","LU1655091616.SGD","LU0359202008.SGD","LU2097828805.USD","LU2580892862.HKD","BK0028","LU1146622755.USD","LU2148510915.USD","LU2488822045.USD","LU1064130708.USD","BK0196","BK0060","LU2097828714.EUR","BK0239","BK1515","159938","BK1191","LU1023057109.AUD","LU2097828557.USD","BK0012","LU2580892789.USD","BK0183","01276","LU1328615791.USD","LU1997244956.HKD","LU1997245094.SGD","LU0359201612.USD","LU0359201885.HKD","LU2495084118.USD","LU1255011170.USD","LU2328871848.SGD","09939","LU2289578879.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106235404","title":"Daiwa Raises CSPC Pharma Target Price to HK$11.2 on In-Line Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1106235404","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106235404?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:46","pubTimestamp":1787557578,"startTime":"0","endTime":"0","summary":"Daiwa has issued a research report noting that CSPC Pharma (01093) posted a 40.1% year-on-year increase in interim revenue to RMB 18.59 billion, aligning with its earlier business guidance and the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","HK0000165453.HKD","LU1328277881.USD","LU1951186391.HKD","LU0501845795.SGD","IE0008368742.USD","LU1960683339.HKD","SG9999004220.SGD","BK1521","LU1813983027.USD","KURE","LU1152091754.HKD","LU2039709279.SGD","IE00BZ08YT58.USD","LU1008478684.HKD","IE0008369823.USD","LU0072913022.USD","IE00B5MMRT66.SGD","LU1152091168.USD","BK1191","LU1226287529.USD","EWH","LU0314109678.HKD","IE00BZ08YR35.GBP","LU1993786604.SGD","LU0140636845.USD","IE00B031HY20.USD","IE00B543WZ88.USD","LU0326950275.SGD","LU0067412154.USD","LU1226287875.USD","LU1226288253.USD","LU0315179316.USD","01093","IE00BZ08YS42.EUR","LU1226287792.SGD","LU1226288170.HKD","LU0880133367.SGD","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150872953","title":"Hong Kong Stock Flash | Baiyunshan (00874) Drops Nearly 6% After Results, Net Profit Falls 16.7% in H1 Due to Higher R&D Spending","url":"https://stock-news.laohu8.com/highlight/detail?id=1150872953","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150872953?lang=en_us&edition=fundamental","pubTime":"2026-08-24 14:49","pubTimestamp":1787554167,"startTime":"0","endTime":"0","summary":"BAIYUNSHAN PH (00874) saw its shares tumble nearly 6% in Hong Kong trading following the release of its interim results, with the stock down 5.64% to HK$14.22 at the time of writing, on a turnover of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","600332","BK1191","BK4585","BK0070","BK0028","BK0196","00874","BK4588","BK0175","BK0188","BK1606","KCAI","BK1515","BK1197","BK0239","BK0096","VXUS","BK0097","BK0183","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661240309","title":"Ascletis Pharma Slips on Expecting Deeper H1 Loss on R&D Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2661240309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661240309?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:43","pubTimestamp":1787542991,"startTime":"0","endTime":"0","summary":"BUZZ-Ascletis Pharma slips on expecting deeper H1 loss on R&D expenses** Shares of Ascletis Pharma Inc1672.HKslip 4.5% to HK$9.565, on track for the biggest one-day pct drop since August 10** The viral diseases and oncology focused pharmaceutical products developerexpects to record net lossof 319.7 million yuan  six months ended in June, as compared with a loss of 88 million yuan the same period a year ago** Company said deeper loss is due to significant increase in research and development expenses as it advances its comprehensive metabolic disease pipeline, including both small molecules and peptides** YTD, stock down 15.9%, while Hang Seng Biotech Index.HSBIOup 9.9%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44L03A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1515","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661024436","title":"Sinopharm Group's Profit Declines 2% in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2661024436","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661024436?lang=en_us&edition=fundamental","pubTime":"2026-08-24 09:10","pubTimestamp":1787533855,"startTime":"0","endTime":"0","summary":"Sinopharm Group's  profit attributable to owners of the parent fell 1.8% in the first six months of 2026 to 3.40 billion yuan from 3.47 billion yuan a year ago, according to a Monday filing to the Hong Kong stock exchange.Earnings per share declined to 1.09 yuan from 1.11 yuan a year earlier, the pharmaceutical company said.Revenue edged down 1.1% to 282.8 billion yuan from 286.04 billion yuan a year ago.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1500","LU1115378108.SGD","BK1197","LU0640798160.USD","BK1515","FCA","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661244886","title":"Guangzhou Baiyunshan Pharma's Profit Falls 17% in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2661244886","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661244886?lang=en_us&edition=fundamental","pubTime":"2026-08-24 09:04","pubTimestamp":1787533464,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical  posted an attributable net profit of 2.10 billion yuan for the first half of 2026, down 17% from 2.52 billion yuan a year earlier.Earnings per share rose to at 1.289 yuan from 1.548 yuan in the year-ago period, according to a Friday Hong Kong bourse filing.Revenue increased 0.61% year over year to 42.1 billion yuan from 41.8 billion yuan.The company proposed a cash dividend of 0.30 yuan per share, inclusive of tax, to all shareholders.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FCA","BK0097","BK1521","BK0183","600332","BK0096","BK0239","BK0175","BK0196","BK0188","BK1191","BK1197","BK0070","BK1606","BK0012","00874","BK0028","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661241804","title":"Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2661241804","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661241804?lang=en_us&edition=fundamental","pubTime":"2026-08-24 08:02","pubTimestamp":1787529767,"startTime":"0","endTime":"0","summary":"Sinopharm interim revenue edges down on softness in pharmaceutical distribution businessOverviewChina pharmaceutical distributor's interim revenue declined slightly year-on-yearNet income attributable","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44K04V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDMCQ","LU0640798160.USD","HK0000306685.HKD","02696","HK0000306701.USD","BK4204","BK1587","00656","02137","BK1500","BK1197","BK1515","BK1161","HK0000320223.HKD","BK1230","LU1115378108.SGD","01099","BK1574","HK0000320264.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224640","title":"Sinopharm Proposes Re-Election of Lian Wanyong, Yang Binghua as Executive Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224640","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661224640?lang=en_us&edition=fundamental","pubTime":"2026-08-24 06:22","pubTimestamp":1787523731,"startTime":"0","endTime":"0","summary":"Sinopharm proposes re-election of Lian Wanyong, Yang Binghua as executive directorsSinopharm flagged a board refresh, proposing to re-elect all current directors for a new three-year term starting Sep","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nNDL5wd0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","LU0640798160.USD","01099","BK1515","BK1500","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661246495","title":"Sinopharm Group H1 Revenue RMB 282,799.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661246495","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661246495?lang=en_us&edition=fundamental","pubTime":"2026-08-24 06:16","pubTimestamp":1787523367,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nPLXXLTJCD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1115378108.SGD","01099","BK1500","LU0640798160.USD","BK1197","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661246450","title":"Sinopharm H1 Net Profit Drops 2.95% to RMB 5.18 Billion; Revenue Slips 1.13% to RMB 282.8 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2661246450","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661246450?lang=en_us&edition=fundamental","pubTime":"2026-08-24 06:15","pubTimestamp":1787523312,"startTime":"0","endTime":"0","summary":"Sinopharm H1 net profit drops 2.95% to RMB 5.18 billion; revenue slips 1.13% to RMB 282.8 billionSinopharm posted profit for the period of RMB 5.18 billion, down 2.95% year-on-year; basic EPS slipped ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nNDLdVNSF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","BK1515","01099","LU0640798160.USD","LU1115378108.SGD","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224557","title":"JD Health International (SEHK:6618) Could Be 43% Undervalued As Half Year Profit Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224557","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661224557?lang=en_us&edition=fundamental","pubTime":"2026-08-24 01:17","pubTimestamp":1787505428,"startTime":"0","endTime":"0","summary":"Why JD Health International’s Latest Earnings Matter For Investors\nJD Health International (SEHK:6618) drew fresh attention after reporting half year 2026 earnings, with higher sales, net income and earnings per share compared with the same period a year earlier.\nSee our latest analysis for JD Health International.\nDespite the stronger half year earnings, JD Health International’s share price tells a mixed story. The stock is at HK$38.66 after a 1 day share price return of 1.63%, yet the year...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4422000-choice1-main-header/1585186589176"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/jd-health-international-sehk6618-could-be-43-undervalued-as","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-6618/jd-health-international-shares/news/jd-health-international-sehk6618-could-be-43-undervalued-as","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SGXZ62798434.SGD","BK1515","86618","BK1589","BK1591","SGXZ86797644.SGD","BK1142","BK1247","LU0456827905.SGD","BK1615","LU0051755006.USD","BK1583","06618","BK1571"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135663784","title":"Dunhuang's Medical Heritage Blends into Tourism, Boosting Wellness Travel Along the Silk Road","url":"https://stock-news.laohu8.com/highlight/detail?id=1135663784","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135663784?lang=en_us&edition=fundamental","pubTime":"2026-08-23 20:51","pubTimestamp":1787489466,"startTime":"0","endTime":"0","summary":"This summer, the rich tapestry of Dunhuang's medical culture—from the \"moxibustion charts\" painted on its ancient grotto walls to the \"prescription collections\" and the legendary \"immortal porridge\"...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159938","BK1515","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":2,"totalSize":221,"code":"91000000","status":"200"}]}}